Cronos Group upgraded to Buy on strong balance sheet, profitability, and growth potential.

Cronos Group Inc., a Canadian cannabis company, has been upgraded to a Buy due to its strong financial position with $827 million in cash, no debt, and improving profitability marked by a 46% adjusted gross margin. The company stands out from its Canadian peers by maintaining positive GAAP operating profit and disciplined cost management. Its valuation is reasonable at about 20 times earnings, supported by net cash that equals half its market capitalization, and it has promising growth opportunities internationally, especially outside the U.S. This upgrade reflects confidence in Cronos' ability to deliver strong returns amid regulatory changes in the cannabis sector.

As of Sep 16, 2026 03:28 WIB, Cronos Group Inc (CRON) is trading at USD 3.23 on Pluang, showing a 3.03% increase over the past day. The company’s market capitalization stands at $1.20 billion, with an enterprise value significantly lower at $405.02 million, highlighting its strong net cash position. This financial strength aligns with the news of Cronos maintaining a net cash balance equal to half its market cap.